Search

David A Shivak

from Oakland, CA
Age ~50

David Shivak Phones & Addresses

  • 1424 Everett Ave, Oakland, CA 94602
  • 3643 Folsom St, San Francisco, CA 94110
  • Newark, CA
  • 65 Lodato Ave, San Mateo, CA 94403 (650) 341-8128
  • 1725 Wright Ave, Mountain View, CA 94043 (650) 965-2690

Work

Company: Sangamo therapeutics, inc. Sep 2017 Position: Director, bioinformatics

Education

Degree: Master of Science, Masters School / High School: Mcmaster University 1995 to 1997 Specialities: Virology

Skills

Bioinformatics • Lifesciences • Molecular Biology • Biotechnology • Biochemistry • Genomics • Life Sciences • Drug Discovery • Informatics • Genetics • Cell Biology • R • Assay Development • Python • Dna • Cell Culture • Perl • Unix Shell Scripting • Ngs • Microarray Analysis • Genome Editing • Pydata • Scientific Programming • Django • Pharmaceutical Industry • Computational Biology

Languages

English

Interests

Science and Technology

Industries

Biotechnology

Resumes

Resumes

David Shivak Photo 1

Director, Bioinformatics

View page
Location:
1424 Everett Ave, Oakland, CA 94602
Industry:
Biotechnology
Work:
Sangamo Therapeutics, Inc.
Director, Bioinformatics

Twist Bioscience Jun 2016 - Sep 2017
Bioinformatics Engineer

Sangamo Therapeutics Dec 2011 - Jun 2016
Bioinformatics Programmer Analyst Iv

Metabolex Aug 2002 - Jan 2012
Informatics Manager

Agy Therapeutics 2000 - 2002
Bioinformatics Scientist
Education:
Mcmaster University 1995 - 1997
Master of Science, Masters, Virology
Skills:
Bioinformatics
Lifesciences
Molecular Biology
Biotechnology
Biochemistry
Genomics
Life Sciences
Drug Discovery
Informatics
Genetics
Cell Biology
R
Assay Development
Python
Dna
Cell Culture
Perl
Unix Shell Scripting
Ngs
Microarray Analysis
Genome Editing
Pydata
Scientific Programming
Django
Pharmaceutical Industry
Computational Biology
Interests:
Science and Technology
Languages:
English

Business Records

Name / Title
Company / Classification
Phones & Addresses
David Shivak
Information Technology Manager and Bioinformatics
METABOLEX, INC
All Other General Merchandise Stores · Home Health Care Services
3876 Bay Ctr Pl, Hayward, CA 94545
(510) 293-8800, (510) 293-9090, (510) 293-8808, (510) 293-8815

Publications

Us Patents

Use Of Biomolecular Targets In The Treatment And Visualization Of Brain Tumors

View page
US Patent:
20070025997, Feb 1, 2007
Filed:
Apr 27, 2006
Appl. No.:
11/413566
Inventors:
Usha Nagavarapu - San Jose CA, US
David Shivak - San Francisco CA, US
Daniel Chin - Foster City CA, US
Erik Foehr - Novato CA, US
Mirella Gonzalez-Zulueta - Pacifica CA, US
International Classification:
A61K 39/395
C12Q 1/68
G01N 33/574
US Classification:
424155100, 435006000, 435007230, 424178100
Abstract:
The present invention relates to the use of proteins that are differentially expressed in primary brain tumor tissues, as compared to normal brain tissues, as biomolecular targets for brain tumor treatment therapies. Specifically, the present invention relates to the use of therapeutic and imaging agents, which specifically bind to one or more of the identified brain tumor protein targets. The present invention also provides compounds and pharmaceutically acceptable compositions for administration in the methods of the invention. Nucleic acid probes specific for the spliced mRNA encoding these variants and affinity reagents specific for the novel proteins are also provided.

Use Of Biomolecular Targets In The Treatment And Visualization Of Brain Tumors

View page
US Patent:
20040001841, Jan 1, 2004
Filed:
Apr 3, 2003
Appl. No.:
10/407365
Inventors:
Usha Nagavarapu - San Jose CA, US
David Shivak - San Mateo CA, US
Daniel Chin - Foster City CA, US
Erik Foehr - Novato CA, US
International Classification:
A61K051/00
A61K039/395
US Classification:
424/178100, 424/001490
Abstract:
The present invention relates to the use of proteins that are differentially expressed in primary brain tumor tissues, as compared to normal brain tissues, as biomolecular targets for brain tumor treatment therapies. Specifically, the present invention relates to the use of therapeutic and imaging agents, which specifically bind to one or more of the identified brain tumor protein targets. The present invention also provides compounds and pharmaceutically acceptable compositions for administration in the methods of the invention. Nucleic acid probes specific for the spliced mRNA encoding these variants and affinity reagents specific for the novel proteins are also provided.

Zinc Finger Nuclease Variants For Treating Or Preventing Lysosomal Storage Diseases

View page
US Patent:
20230048224, Feb 16, 2023
Filed:
Oct 30, 2020
Appl. No.:
17/773507
Inventors:
- Richmond CA, US
Marshall Huston - Richmond CA, US
David Shivak - Richmond CA, US
International Classification:
C12N 9/22
C12N 15/90
Abstract:
The present disclosure provides 2-in-1 zinc finger nuclease variants and methods of treating and/or preventing a lysosomal storage disorder using said zinc finger nuclease variants.
David A Shivak from Oakland, CA, age ~50 Get Report